List of Tables
Table 1. Neuroprotective Agents CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Neuroprotective Agents Market Trends
Table 3. Neuroprotective Agents Market Drivers
Table 4. Neuroprotective Agents Market Challenges
Table 5. Neuroprotective Agents Market Restraints
Table 6. Global Neuroprotective Agents Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Neuroprotective Agents Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Neuroprotective Agents Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Neuroprotective Agents Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Neuroprotective Agents Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Neuroprotective Agents Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Neuroprotective Agents Revenue Share by Manufacturer, 2017-2022
Table 13. Global Neuroprotective Agents Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global Neuroprotective Agents Sales Share by Manufacturer, 2017-2022
Table 15. Global Neuroprotective Agents Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Neuroprotective Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Neuroprotective Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroprotective Agents as of 2021)
Table 18. Top Players of Neuroprotective Agents in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Neuroprotective Agents Product Type
Table 20. Date of International Manufacturers Enter into Neuroprotective Agents Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Neuroprotective Agents Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Neuroprotective Agents Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Neuroprotective Agents Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Neuroprotective Agents Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States Neuroprotective Agents Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Neuroprotective Agents Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Neuroprotective Agents Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global Neuroprotective Agents Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global Neuroprotective Agents Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Neuroprotective Agents Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Neuroprotective Agents Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America Neuroprotective Agents Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Neuroprotective Agents Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific Neuroprotective Agents Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Neuroprotective Agents Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe Neuroprotective Agents Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Neuroprotective Agents Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa Neuroprotective Agents Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Neuroprotective Agents Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa Neuroprotective Agents Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Genervon Biopharmaceuticals Corporation Information
Table 43. Genervon Biopharmaceuticals Description and Business Overview
Table 44. Genervon Biopharmaceuticals Neuroprotective Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. Genervon Biopharmaceuticals Neuroprotective Agents Product
Table 46. Genervon Biopharmaceuticals Recent Development
Table 47. NeuroVive Pharmaceutical Corporation Information
Table 48. NeuroVive Pharmaceutical Description and Business Overview
Table 49. NeuroVive Pharmaceutical Neuroprotective Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. NeuroVive Pharmaceutical Product
Table 51. NeuroVive Pharmaceutical Recent Development
Table 52. Ceregene Corporation Information
Table 53. Ceregene Description and Business Overview
Table 54. Ceregene Neuroprotective Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Ceregene Product
Table 56. Ceregene Recent Development
Table 57. Neuren Pharmaceuticals Corporation Information
Table 58. Neuren Pharmaceuticals Description and Business Overview
Table 59. Neuren Pharmaceuticals Neuroprotective Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. Neuren Pharmaceuticals Product
Table 61. Neuren Pharmaceuticals Recent Development
Table 62. Allon Therapeutics Corporation Information
Table 63. Allon Therapeutics Description and Business Overview
Table 64. Allon Therapeutics Neuroprotective Agents Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. Allon Therapeutics Product
Table 66. Allon Therapeutics Recent Development
Table 67. Key Raw Materials Lists
Table 68. Raw Materials Key Suppliers Lists
Table 69. Neuroprotective Agents Customers List
Table 70. Neuroprotective Agents Distributors List
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Neuroprotective Agents Product Picture
Figure 2. Global Neuroprotective Agents Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Neuroprotective Agents Market Size 2017-2028 (US$ Million)
Figure 4. Global Neuroprotective Agents Sales 2017-2028 (K MT)
Figure 5. United States Neuroprotective Agents Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Neuroprotective Agents Market Size 2017-2028 (US$ Million)
Figure 7. United States Neuroprotective Agents Sales 2017-2028 (K MT)
Figure 8. United States Neuroprotective Agents Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Neuroprotective Agents Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. Neuroprotective Agents Report Years Considered
Figure 11. Product Picture of Cerebrovascular Diseases
Figure 12. Product Picture of Neurodegenerative Disorders
Figure 13. Product Picture of Ophthalmic Diseases
Figure 14. Product Picture of Traumatic CNS Injuries
Figure 15. Global Neuroprotective Agents Market Share by Type in 2022 & 2028
Figure 16. Global Neuroprotective Agents Sales in Value by Type (2017-2028) & (US$ Million)
Figure 17. Global Neuroprotective Agents Sales Market Share in Value by Type (2017-2028)
Figure 18. Global Neuroprotective Agents Sales by Type (2017-2028) & (K MT)
Figure 19. Global Neuroprotective Agents Sales Market Share in Volume by Type (2017-2028)
Figure 20. Global Neuroprotective Agents Price by Type (2017-2028) & (USD/MT)
Figure 21. United States Neuroprotective Agents Market Share by Type in 2022 & 2028
Figure 22. United States Neuroprotective Agents Sales in Value by Type (2017-2028) & (US$ Million)
Figure 23. United States Neuroprotective Agents Sales Market Share in Value by Type (2017-2028)
Figure 24. United States Neuroprotective Agents Sales by Type (2017-2028) & (K MT)
Figure 25. United States Neuroprotective Agents Sales Market Share in Volume by Type (2017-2028)
Figure 26. United States Neuroprotective Agents Price by Type (2017-2028) & (USD/MT)
Figure 27. Product Picture of Hospitals
Figure 28. Product Picture of Clinics
Figure 29. Product Picture of Others
Figure 30. Global Neuroprotective Agents Market Share by Application in 2022 & 2028
Figure 31. Global Neuroprotective Agents Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Neuroprotective Agents Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Neuroprotective Agents Sales by Application (2017-2028) & (K MT)
Figure 34. Global Neuroprotective Agents Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Neuroprotective Agents Price by Application (2017-2028) & (USD/MT)
Figure 36. United States Neuroprotective Agents Market Share by Application in 2022 & 2028
Figure 37. United States Neuroprotective Agents Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Neuroprotective Agents Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Neuroprotective Agents Sales by Application (2017-2028) & (K MT)
Figure 40. United States Neuroprotective Agents Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Neuroprotective Agents Price by Application (2017-2028) & (USD/MT)
Figure 42. North America Neuroprotective Agents Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 43. North America Neuroprotective Agents Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Neuroprotective Agents Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 47. Europe Neuroprotective Agents Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Neuroprotective Agents Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 54. Asia-Pacific Neuroprotective Agents Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Taiwan Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Philippines Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Latin America Neuroprotective Agents Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 66. Latin America Neuroprotective Agents Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 67. Mexico Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Brazil Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Argentina Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Middle East & Africa Neuroprotective Agents Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 71. Middle East & Africa Neuroprotective Agents Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Turkey Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Saudi Arabia Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. U.A.E Neuroprotective Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Neuroprotective Agents Value Chain
Figure 76. Neuroprotective Agents Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
